Vaia Florou

Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial

Breelyn A. Wilky, Matteo Trucco, Ty K. Subhawong et al. · The Lancet Oncology · 2019 · 385 citations

Medicine, Oncology, Pharmacology +11

Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution

Vaia Florou, Andrew E. Rosenberg, Eric Wieder et al. · Journal for ImmunoTherapy of Cancer · 2019 · 181 citations · Full text

Medicine, Immunology, Oncology +17

Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort

Abdul Rafeh Naqash, Biagio Ricciuti, Dwight H. Owen et al. · Cancer Immunology Immunotherapy · 2020 · 97 citations · Full text

Medicine, Immunology, Oncology +15

Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium

Talal El Zarif, Amin H. Nassar, Elio Adib et al. · Journal of Clinical Oncology · 2023 · 69 citations · Full text

Life Sciences, Immunology, Oncology +17

Clinical and Immunological Implications of Frameshift Mutations in Lung Cancer

Young Kwang Chae, Pedro Viveiros, Gilberto Lopes et al. · Journal of Thoracic Oncology · 2019 · 49 citations

Medicine, Immunology, Oncology +16